Lauren Rusckowski Duprey, Chief Transformation Officer at TAKEDA PHARMACEUTICAL CO LTD (TAK), sold 47,586 shares at $17.10 ($814K) on 2026-08-10, disclosed to the SEC on 2026-08-12.
Open-market sale of $814k TAK by Chief Transformation Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.